New Study: Medicare’s Price Controls Are Fueling America’s Growing Doctor Shortage
The Pacific Research Institute’s Center for Medical Economics and Innovation today released a new issue brief warning that continued federal underpayment of doctors is fueling a looming healthcare crisis by accelerating the nation’s physician shortage and undermining access to care. Written by PRI senior fellow in business and economics and CMEI director Dr. Wayne Winegarden, the brief (titled “It’s Time for Medicare to Stop Shortchanging Physicians”) finds that Medicare reimbursement rates are well below market ...
Open, Competitive Market Will Make Trump’s Health Plan Great
President Trump’s recently released Great Healthcare Plan offers several welcome reforms. It endeavors to put patients first by fostering greater price transparency and taking steps to lower health insurance premiums. Its approach to prescription drug policy is a bit more mixed. Read the op-ed here.
CMS Officials Are Undermining Trump’s Push For Affordable Drugs
Officials at the Centers for Medicare and Medicaid Services just undermined President Trump’s efforts to make prescription drugs more affordable. Earlier this week, CMS announced the next 15 medicines that will face price caps under Medicare’s Drug Price “Negotiation” Program, a core component of the Inflation Reduction Act signed into law by President Biden in 2022. The IRA legally obligates the Trump administration to select 15 medicines for price controls by February 1. But the ...
Trending Topics
Studies
